Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10090-2-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10090-2-AP, RRID:AB_2058518
- Product name
- ARL2BP antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated ARL2BP antibody (Cat. #10090-2-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Mutations in ARL2BP, encoding ADP-ribosylation-factor-like 2 binding protein, cause autosomal-recessive retinitis pigmentosa.
BART inhibits pancreatic cancer cell invasion by PKCĪ± inactivation through binding to ANX7.
BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.
BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP.
Truncation mutation in HRG4 (UNC119) leads to mitochondrial ANT-1-mediated photoreceptor synaptic and retinal degeneration by apoptosis.
Davidson AE, Schwarz N, Zelinger L, Stern-Schneider G, Shoemark A, Spitzbarth B, Gross M, Laxer U, Sosna J, Sergouniotis PI, Waseem NH, Wilson R, Kahn RA, Plagnol V, Wolfrum U, Banin E, Hardcastle AJ, Cheetham ME, Sharon D, Webster AR
American journal of human genetics 2013 Aug 8;93(2):321-9
American journal of human genetics 2013 Aug 8;93(2):321-9
BART inhibits pancreatic cancer cell invasion by PKCĪ± inactivation through binding to ANX7.
Taniuchi K, Yokotani K, Saibara T
PloS one 2012;7(4):e35674
PloS one 2012;7(4):e35674
BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.
Taniuchi K, Yokotani K, Saibara T
Neoplasia (New York, N.Y.) 2012 May;14(5):440-50
Neoplasia (New York, N.Y.) 2012 May;14(5):440-50
BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
Taniuchi K, Iwasaki S, Saibara T
International journal of oncology 2011 Nov;39(5):1243-52
International journal of oncology 2011 Nov;39(5):1243-52
Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP.
Taniuchi K, Nishimori I, Hollingsworth MA
Cancer research 2011 Feb 1;71(3):895-905
Cancer research 2011 Feb 1;71(3):895-905
Truncation mutation in HRG4 (UNC119) leads to mitochondrial ANT-1-mediated photoreceptor synaptic and retinal degeneration by apoptosis.
Mori N, Ishiba Y, Kubota S, Kobayashi A, Higashide T, McLaren MJ, Inana G
Investigative ophthalmology & visual science 2006 Apr;47(4):1281-92
Investigative ophthalmology & visual science 2006 Apr;47(4):1281-92
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Transfected HEK-293 cells were subjected to SDS PAGE followed by western blot with 10090-2-AP( ARL2BP Antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human gliomas using 10090-2-AP(ARL2BP antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ARL2BP antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ARL2BP. This antibody recognizes human,mouse,rat antigen. The ARL2BP antibody has been validated for the following applications: ELISA, IHC, WB analysis.
